1) Reduction in severity of symptoms (VAS; temperature etc) in mild cases <br/ >2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls <br/ >3) Reduction in transmission of infection among household members of COVID-19 patient <br/ >Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days <br/ >2) Baseline swab test and swab test once every 3 days till two successive tests are negative <br/ >3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern. <br/ >

1) Reduction in severity of symptoms (VAS; temperature etc) in mild cases <br/ >2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls <br/ >3) Reduction in transmission of infection among household members of COVID-19 patient <br/ >Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days <br/ >2) Baseline swab test and swab test once every 3 days till two successive tests are negative <br/ >3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern. <br/ >

N/A

N/A

1) Reduction in severity of symptoms (VAS; temperature etc) in mild cases <br/ >2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls <br/ >3) Reduction in transmission of infection among household members of COVID-19 patient <br/ >Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days <br/ >2) Baseline swab test and swab test once every 3 days till two successive tests are negative <br/ >3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern. <br/ >

1) Reduction in severity of symptoms (VAS; temperature etc) in mild cases <br/ >2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls <br/ >3) Reduction in transmission of infection among household members of COVID-19 patient <br/ >Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days <br/ >2) Baseline swab test and swab test once every 3 days till two successive tests are negative <br/ >3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern. <br/ >